public policy consulting
1225 I Street, NW, #1010 Washington DC 20005, Washington, DC · MR. MICHAEL WERNER
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2009 | SHIRE PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination |
$20,000 | — | |
| 2009 | BIOTECHNOLOGY INDUSTRY ORGANIZATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination |
$25,000 | — | |
| 2008 | SHIRE PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$30,000 | — | |
| 2008 | BIOTECHNOLOGY INDUSTRY ORGANIZATION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$40,000 | — | |
| 2008 | SHIRE PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$30,000 | — | |
| 2008 | BIOTECHNOLOGY INDUSTRY ORGANIZATION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$40,000 | — | |
| 2008 | SHIRE PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$30,000 | — | |
| 2008 | BIOTECHNOLOGY INDUSTRY ORGANIZATION |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$40,000 | — | |
| 2008 | BIOTECHNOLOGY INDUSTRY ORGANIZATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$40,000 | — | |
| 2008 | SHIRE PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| BIOTECHNOLOGY INDUSTRY ORGANIZATION | 7 | $340,000 |
| SHIRE PHARMACEUTICALS | 6 | $140,000 |
| SHIRE HUMAN GENETIC THERAPIES | 3 | $80,000 |
| UCARE MINNESOTA | 2 | $42,000 |
| COMMUNITY HEALTH CHARITIES | 1 | $20,000 |
| Name | Disclosed Prior Position |
|---|---|
| MICHAEL WERNER | N/A |